Advent International and Essex Woodlands fully exited Brazilian pharmaceutical company Biotoscana through a strategic sale to Canadian pharmaceutical company Knight Therapeutics. Advent and Essex Woodlands ‘s 51% stake was purchased…
-
-
Brazilian pharmaceutical company Eurofarma launched Axon Ventures, a R$45m early-stage CVC fund. (Baguete) A Eurofarma, farmacêutica brasileira presente em 20 países, vai investir em projetos de tecnologia focados no setor…
-
Carao Ventures led a US$2m follow-on investment in Speratum, a Costa Rican biotech focused on microRNA-directed oncology therapies primarily for pancreatic and ovarian cancers. Carao previously invested US$800k when Speratum…